BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Cheng T, He Y, Zhou S, Wang Y, Zhang K, Yu P. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway. Life Sci. 2019;232:116602. [PMID: 31251997 DOI: 10.1016/j.lfs.2019.116602] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Dai C, Chen H, Wang F, Hua Z, Xia L, Yuan L, Qin L. Lung cancer and miRNAs: a possible remedy for anti-metastatic, therapeutic and diagnostic applications.. [DOI: 10.21203/rs.3.rs-2575764/v1] [Reference Citation Analysis]
2 Xu J, Wang X, Zhu C, Wang K. A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers. Front Cell Dev Biol 2022;10:997633. [PMID: 36544907 DOI: 10.3389/fcell.2022.997633] [Reference Citation Analysis]
3 Cheng Y, Wu X, Xia Y, Liu W, Wang P. The role of lncRNAs in regulation of DKD and diabetes-related cancer. Front Oncol 2022;12:1035487. [DOI: 10.3389/fonc.2022.1035487] [Reference Citation Analysis]
4 Jones JC, Bodenstine TM. Connexins and Glucose Metabolism in Cancer. Int J Mol Sci 2022;23:10172. [PMID: 36077565 DOI: 10.3390/ijms231710172] [Reference Citation Analysis]
5 Li M, Liao H, Wu J, Chen B, Pang R, Huang J, Zhu Y. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1. Bioengineered 2021;12:12880-90. [PMID: 34895065 DOI: 10.1080/21655979.2021.2005986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang J, Jing M, Chen X, Gao Y, Hua H, Pan C, Wu J, Wang X, Chen X, Gao Y, Xu C, Li P. ERp29 forms a feedback regulation loop with microRNA-135a-5p and promotes progression of colorectal cancer. Cell Death Dis 2021;12:965. [PMID: 34667160 DOI: 10.1038/s41419-021-04252-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Kang Q, Tong Y, Gowd V, Wang M, Chen F, Cheng KW. Oral administration of EGCG solution equivalent to daily achievable dosages of regular tea drinkers effectively suppresses miR483-3p induced metastasis of hepatocellular carcinoma cells in mice. Food Funct 2021;12:3381-92. [PMID: 33900350 DOI: 10.1039/d1fo00664a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Supabphol S, Seubwai W, Wongkham S, Saengboonmee C. High glucose: an emerging association between diabetes mellitus and cancer progression. J Mol Med (Berl) 2021;99:1175-93. [PMID: 34036430 DOI: 10.1007/s00109-021-02096-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
9 Wang Z, Zhang J, Wen Y, Wang P, Fan L. Bupivacaine inhibits the malignant biological behavior of oral squamous cell carcinoma cells by inhibiting the activation of ERK1/2 and STAT3. Ann Transl Med 2021;9:839. [PMID: 34164473 DOI: 10.21037/atm-21-1414] [Reference Citation Analysis]
10 Balihodzic A, Barth DA, Prinz F, Pichler M. Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer. Cancers (Basel) 2021;13:977. [PMID: 33652661 DOI: 10.3390/cancers13050977] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
11 Holvoet P. Regulation of Non-coding RNAs in Cardiometabolic Tissues and Tumors. Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer 2021. [DOI: 10.1007/978-3-030-68844-8_8] [Reference Citation Analysis]
12 Niu ZS, Wang WH, Dong XN, Tian LML. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma. World J Gastroenterol 2020; 26(29): 4240-4260 [PMID: 32848331 DOI: 10.3748/wjg.v26.i29.4240] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
13 Zhao L, Chen T, Tang X, Li S, Liang R, Wang Y. Medulloblastoma malignant biological behaviors are associated with HOTAIR/miR-483-3p/CDK4 axis. Ann Transl Med 2020;8:886. [PMID: 32793730 DOI: 10.21037/atm-20-5006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 He Y, Huang S, Cheng T, Wang Y, Zhou SJ, Zhang YM, Yu P. High glucose may promote the proliferation and metastasis of hepatocellular carcinoma via E2F1/RRBP1 pathway. Life Sci 2020;252:117656. [PMID: 32289433 DOI: 10.1016/j.lfs.2020.117656] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
15 Shi Z, Xiao Z, Hu L, Gao Y, Zhao J, Liu Y, Shen G, Xu Q, Huang D. The genetic association between type 2 diabetic and hepatocellular carcinomas. Ann Transl Med 2020;8:380. [PMID: 32355824 DOI: 10.21037/atm.2020.02.13] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]